Schedule 13D ownership disclosure

REPLICEL LIFE SCIENCES INC.

Security class unavailable · CUSIP: 76027P400

Event date: 2018-05-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,295,415
Percent of class
6.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000892303-18-000006
Form type
SC 13D
Filer
REPLICEL LIFE SCIENCES INC.
CIK
CIK 1205059
Filed
Sep 12, 2018
Reporting period
May 11, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub